Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma (BCC)
originates from the basal layer
of the skin's epidermis and
stands as the predominant type
of skin cancer in Australia,
comprising approximately
three-quarters of all cases
treated. Unlike some cancers
that metastasize through the
bloodstream or lymphatic
system, BCC typically remains
localized. Nonetheless, its potential to infiltrate and harm underlying tissue structures
in specific body regions underscores its severity.
Predominantly manifesting on sun-exposed areas, such as the face, BCCs may also develop in less exposed regions. They commonly present as pink or skin-toned growths, occasionally exhibiting a brown hue. Two primary variants of BCC exist: nodular and superficial. Nodular BCCs manifest as painless, small lumps that may occasionally ulcerate or bleed, while superficial BCCs resemble flat, scaly, pink areas. Additionally, certain rare subtypes of Basal Cell Carcinoma pose greater diagnostic challenges due to their atypical presentations.
It is imperative to note that individuals diagnosed with BCC on the face are at an elevated risk of developing subsequent lesions. This heightened susceptibility underscores the importance of ongoing surveillance for all individuals with a history of skin cancer, ensuring prompt identification and intervention for any emerging malignancies. As with any cancer, early detection and timely treatment significantly enhance the prospects for a successful outcome.
IF YOU HAVE PREVIOUSLY BEEN DIAGNOSED WITH BCC OR SUSPECT THE PRESENCE OF A SUSPICIOUS LESION, WE ENCOURAGE YOU TO CONTACT US FOR A COMPREHENSIVE EVALUATION. PLEASE CALL 1300 378 336 TO SCHEDULE AN APPOINTMENT.
Predominantly manifesting on sun-exposed areas, such as the face, BCCs may also develop in less exposed regions. They commonly present as pink or skin-toned growths, occasionally exhibiting a brown hue. Two primary variants of BCC exist: nodular and superficial. Nodular BCCs manifest as painless, small lumps that may occasionally ulcerate or bleed, while superficial BCCs resemble flat, scaly, pink areas. Additionally, certain rare subtypes of Basal Cell Carcinoma pose greater diagnostic challenges due to their atypical presentations.
It is imperative to note that individuals diagnosed with BCC on the face are at an elevated risk of developing subsequent lesions. This heightened susceptibility underscores the importance of ongoing surveillance for all individuals with a history of skin cancer, ensuring prompt identification and intervention for any emerging malignancies. As with any cancer, early detection and timely treatment significantly enhance the prospects for a successful outcome.
IF YOU HAVE PREVIOUSLY BEEN DIAGNOSED WITH BCC OR SUSPECT THE PRESENCE OF A SUSPICIOUS LESION, WE ENCOURAGE YOU TO CONTACT US FOR A COMPREHENSIVE EVALUATION. PLEASE CALL 1300 378 336 TO SCHEDULE AN APPOINTMENT.
